Increased number of Th22 cells and correlation with Th17 cells in peripheral blood of patients with IgA nephropathy

Human Immunology

Volumn 74, Issue 12, 2013, Pages 1586-1591

  Peng, Zhiguo ^a   Tian, Jun ^a   Cui, Xianquan ^a   Xian, Wanhua ^a   Sun, Huaibin ^a   Li, Engang ^a   Geng, Lina ^a   Zhang, Luwei ^a   Zhao, Peng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22;

ADULT; ARTICLE; BLOOD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN URINE LEVEL; PROTEINURIA; TH17 CELL; TH22 CELL; URINARY EXCRETION;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOPHENOTYPING; INTERLEUKINS; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH17 CELLS; YOUNG ADULT;

EID: 84888201065     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.08.001     Document Type: Article

References (35)

1. Sanders J.T., Wyatt R.J. IgA nephropathy and Henoch-Schonlein purpura nephritis. Curr Opin Pediatr 2008, 20:163-170.
2. Roufosse C.A., Cook H.T. Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens 2009, 18:212-219.
3. Huang H., Peng Y., Liu F., Lei H. Is IgA nephropathy induced by abnormalities of CD4+CD25+ Treg cells in the tonsils?. Med Hypotheses 2007, 69:410-413.
4. Lai K., Ho R., Lai C., Chan C., Li P. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol 1994, 96:116-121.
5. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
6. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
7. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
8. Lin F.J., Jiang G.R., Shan J.P., Zhu C., Zou J., Wu X.R. Imbalance of regulatory T cells to Th17 cells in IgA nephropathy. Scand J Clin Lab Invest 2012, 72:221-229.
9. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009, 10:857-863.
10. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009, 119:3573-3585.
11. Trifari S., Kaplan C.D., Tran E.H., Crellin N.K., Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009, 10:864-871.
12. Cosmi B., Legnani C., Cini M., Favaretto E., Palareti G. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Res 2008, 122:610-617.
13. Ramirez J.M., Brembilla N.C., Sorg O., Chicheportiche R., Matthes T., Dayer J.M., et al. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 2010, 40:2450-2459.
14. Kagami S., Rizzo H.L., Lee J.J., Koguchi Y., Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010, 130:1373-1383.
15. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin Immunopathol 2010, 32:17-31.
16. Brand S., Beigel F., Olszak T., Zitzmann K., Eichhorst S.T., Otte J.M., et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 2006, 290:G827-G838.
17. Lo Y.H., Torii K., Saito C., Furuhashi T., Maeda A., Morita A. Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy. J Dermatol Sci 2010, 58:225-227.
18. Zhang L., Li J.M., Liu X.G., Ma D.X., Hu N.W., Li Y.G., et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 2011, 31:606-614.
19. Cheng F., Guo Z., Xu H., Yan D., Li Q. Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2009, 68:604-606.
20. Lai K.N., Ho R.T., Lai C.K., Chan C.H., Li P.K. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol 1994, 96:116-121.
21. Zhuang Y., Peng L.S., Zhao Y.L., Shi Y., Mao X.H., Guo G., et al. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer Immunol Immunother 2012, 61:1965-1975.
22. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
23. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
24. Volpe E., Servant N., Zollinger R., Bogiatzi S.I., Hupe P., Barillot E., et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008, 9:650-657.
25. Lim C.S., Zheng S., Kim Y.S., Ahn C., Han J.S., Kim S., et al. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant 2001, 16:269-275.
26. Lejeune D., Dumoutier L., Constantinescu S., Kruijer W., Schuringa J.J., Renauld J.C. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002, 277:33676-33682.
27. Geddes C.C., Rauta V., Gronhagen-Riska C., Bartosik L.P., Jardine A.G., Ibels L.S., et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003, 18:1541-1548.
28. Ruggenenti P., Perna A., Mosconi L., Pisoni R., Remuzzi G. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int 1998, 53:1209-1216.
29. Donadio J.V., Bergstralh E.J., Grande J.P., Rademcher D.M. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant 2002, 17:1197-1203.
30. Zoja C., Donadelli R., Colleoni S., Figliuzzi M., Bonazzola S., Morigi M., et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998, 53:1608-1615.
31. Morigi M., Macconi D., Zoja C., Donadelli R., Buelli S., Zanchi C., et al. Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 2002, 13:1179-1189.
32. Zoja C., Benigni A., Remuzzi G. Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 2004, 13:31-37.
33. Tang S., Leung J.C., Abe K., Chan K.W., Chan L.Y., Chan T.M., et al. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 2003, 111:515-527.
34. Reich H.N., Troyanov S., Scholey J.W., Cattran D.C. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol 2007, 18:3177-3183.
35. Choi S., Lee D., Jeong K.H., Moon J.Y., Lee S.H., Lee T.W., et al. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers. Clin Nephrol 2009, 72:353-359.